image
Utah Medical Products, Inc. UTMD
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
Watchlist
$ 66.05
-0.707 %
$ 224 M
Market Cap
15.43
P/E
INCOME STATEMENT
50.2 M REVENUE
-3.93%
Growth Rates
1Year -3.93%
3Years 5.99%
5Years 3.64%
7Years 3.57%
10Years 2.18%
16.8 M OPERATING INCOME
32.02%
Growth Rates
1Year 32.02%
3Years 37.18%
5Years -2.14%
7Years 0.51%
10Years 1.24%
16.6 M NET INCOME
0.98%
Growth Rates
1Year 0.98%
3Years 15.49%
5Years -2.16%
7Years 4.62%
10Years 3.85%
EFFICIENCY
Earnings Waterfall Utah Medical Products, Inc.
image
Revenue 50.2 M
Cost Of Revenue 20.2 M
Gross Profit 30 M
Operating Expenses 13.3 M
Operating Income 16.8 M
Other Expenses 142 K
Net Income 16.6 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995 Dec-1994 Dec-1993 Dec-1992 Dec-1991 Dec-1990 Dec-1989 Dec-1988 Dec-1987
REVENUE
Revenue 50.2 52.3 49.1 42.2 46.9 42.0 41.4 39.3 40.2 41.3 40.5 41.6 37.9 25.1 25.9 27.8 28.5 28.8 27.7 26.5 27.1 27.4 27.0 27.2 29.4 27.7 24.3 38.7 42.0 39.6 37.0 36.1 29.8 23.9 17.9 13.5 7.6
GROSS PROFIT
Cost Of Revenue 20.2 20.1 18.1 16.6 17.4 15.7 15.0 15.6 16.0 16.3 16.2 16.2 15.5 11.9 12.1 12.8 12.7 12.6 11.9 11.4 11.2 11.6 11.6 12.1 11.5 11.4 10.2 18.1 20.8 20.7 19.5 19.3 16.9 14.0 10.5 8.4 4.8
Gross Profit 30.0 32.2 30.9 25.5 29.5 26.3 26.4 23.7 24.2 25.0 24.3 25.3 22.4 13.2 13.8 15.0 15.8 16.1 15.8 15.1 15.9 15.8 15.4 15.1 18.0 16.3 14.1 20.6 21.2 18.9 17.5 16.8 12.9 9.9 7.4 5.1 2.8
OPERATING INCOME
Operating Expenses 13.3 12.4 12.0 11.8 11.8 7.6 7.4 7.5 8.5 8.8 9.4 10.1 10.6 4.3 4.4 4.6 5.0 5.3 6.5 5.0 5.2 5.2 6.1 6.8 9.7 9.6 8.6 8.7 9.5 8.9 8.6 7.4 4.9 3.9 3.5 3.1 2.1
Selling, General and Administrative Expenses 12.7 11.9 11.5 11.4 11.4 7.2 6.9 7.0 8.0 8.3 9.0 9.5 10.0 3.9 4.0 4.3 4.7 5.0 6.2 4.7 4.9 4.9 5.8 6.2 6.8 6.6 6.1 5.9 6.0 6.1 7.6 6.5 4.3 3.4 3.0 2.5 1.7
Research and Development Expenses 0.6 0.5 0.5 0.5 0.5 0.5 0.4 0.5 0.5 0.5 0.5 0.6 0.5 0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.4 0.6 0.7 0.9 1.0 1.4 1.8 1.5 0 0 0 0 0 0 0
Operating Income 16.8 12.7 18.9 6.5 10.8 18.7 19.0 16.2 15.7 16.2 14.8 15.2 11.8 8.9 9.4 10.4 10.8 10.8 9.2 10.1 10.7 10.5 9.3 8.4 8.3 6.7 5.5 11.9 11.7 10.0 8.9 9.4 8.0 6.0 3.9 2.0 0.7
PRE-TAX INCOME
Interest Income Expense 0 (0.9) 0 0 0 0 0 0 65 K 0.3 0.4 0.7 0.9 25 K 51 K 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Other Income 3.3 0.9 0.2 0.1 0.3 0.8 71 K 0.2 (0.1) (0.4) (0.4) (0.7) (0.8) 0.1 0.1 0.4 1.3 1.6 1.0 (0.7) 0.5 0.5 0.2 53 K 0.3 0.9 1.3 1.8 1.2 0.9 1.7 1.2 0.3 0.7 0.2 0 0
Pre-Tax Income 20.1 20.7 19.1 13.8 17.9 19.5 19.1 16.4 15.5 15.8 14.5 14.5 11.1 9.0 9.6 10.8 12.0 12.4 10.2 10.9 11.2 11.0 9.5 8.4 8.5 7.6 6.8 13.7 12.9 10.9 10.6 10.6 8.3 6.7 4.1 2.0 0.7
NET INCOME
Tax Provision 3.5 4.2 4.3 3.0 3.2 0.9 10.6 4.3 3.7 4.4 3.1 4.4 3.7 3.0 3.3 3.6 4.1 4.2 2.7 3.7 3.8 3.8 3.5 3.0 3.1 2.7 2.5 4.9 4.5 3.8 3.6 3.7 2.9 2.4 1.5 0.6 0.3
Net Income 16.6 16.5 14.8 10.8 14.7 18.6 8.5 12.1 11.8 11.4 11.4 10.2 7.4 6.0 6.3 7.2 7.9 8.2 7.5 10.2 20.8 7.2 5.9 5.4 5.5 4.9 4.3 8.8 8.4 7.1 7.0 6.9 5.4 4.3 2.6 1.4 0.4
EPS 4.57 4.53 4.05 2.95 3.96 4.97 2.29 3.22 3.14 3.02 3.02 2.74 2.04 1.66 1.73 1.87 2.01 2.07 1.91 2.32 4.59 1.46 1.18 0.9 0.76 0.59 0.51 0.94 0.83 0.68 0.6 0.58 0.46 0.37 0.23 0.13 0.04